Quantification of ciprofloxacin in human plasma by validated LC-MS/MS using ofloxacin as an internal standard and its clinical application

Current Pharmaceutical Analysis

Volumn 11, Issue 4, 2015, Pages 239-247

  Kim, Sang Yeon ^a   Song, Il Dong ^a   Kim, Hyun Jin ^a   Park, Yoo Sin ^a   Kim, Shin Hee ^a   Kang, Min A ^b   Kim, Do Wan ^c   Kang, Ju Seop ^a  

^a Hanyang University   (South Korea)

^b Yonsei University   (South Korea)

^c Ajou University   (South Korea)

Author keywords

Bioequivalence; Ciprofloxacin; Internal standard; LC MS; Liquid liquid extraction; MS; Pharmacokinetics

Indexed keywords

AMMONIUM ACETATE; CIPROFLOXACIN; DICHLOROMETHANE; ETHER; METHANOL; OFLOXACIN;

ADULT; ARTICLE; BIOEQUIVALENCE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG FORMULATION; DRUG IMPURITY; DRUG RETENTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LIMIT OF QUANTITATION; LIQUID LIQUID EXTRACTION; MALE; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; STANDARD;

EID: 84937146555     PISSN: 15734129     EISSN: 1875676X     Source Type: Journal    
DOI: 10.2174/1573412911666150331224024     Document Type: Article

References (41)

1. Nelson, J.M.; Chiller, T.M.; Powers, J.H.; Angulo, F.J. Fluoroquinolone-resistant Campylobacter species and the withdrawal of fluoroquinolones from use in poultry: a public health success story. Clin. Infect. Dis., 2007, 44(7), 977-980.
2. Kawahara, S. Chemotherapeutic agents under study. Nippon. Rinsho. Jpn. J. Clin. Med., 1998, 56(12), 3096-3099.
3. AHFS DRUG informations. American society of Health System Pharmacists: ciprofloxacin. 2011.
4. Drlica, K. Biology of bacterial deoxyribonucleic acid topoisomerases. Microbiol. Rev., 1984, 48(4), 273-289.
5. Hooper, D.C.; Wolfson, J.S.; Ng, E.Y.; Swartz, M.N. Mechanisms of action of and resistance to ciprofloxacin. Am. J. Med., 1987, 82(4A), 12-20.
6. Vance-Bryan, K.; Guay, D.R.; Rotschafer, J.C. Clinical pharmacokinetics of ciprofloxacin. Clin. Pharmacokinet., 1990, 19(6), 434-461.
7. Drlica, K.; Zhao, X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol. Mol. Biol. Rev., 1997, 61(3), 377-392.
8. Linder, J.A.; Huang, E.S.; Steinman, M.A.; Gonzales, R; Stafford, R.S. Fluoroquinolone prescribing in the United States 1995 to 2002. Am. J. Med., 2005, 118(3), 259-268.
9. Wikipedia. Ciprofloxacin. http://en.wikipedia.org/wiki/ Ciprofloxacin (Accessed Mar 17, 2015)
10. Update on extra-label use of fluoroquinolones. Center for Veterinary Medicine(CVM). FDA, 1996. http://www. fda. gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm127657. Htm (Accessed Aug 12, 2009)
11. Esposito, S.; Galante, D.; Barba, D.; D'Errico, G.; Mazzone, A.; Montanaro, S. Ciprofloxacin concentrations in human fluids and tissues following a single oral dose. Int. J. Clin. Pharmacol. Res., 1987, 7(3), 181-186.
12. Borner, K.; Hoffken, G.; Lode, H.; Koeppe, P.; Prinzing, C.; Glatzel, P.; Wiley, R.; Olschewski, P.; Sievers, B.; Reinitz, D. Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration. Eur. J. Clin. Microbiol., 1986, 5(2), 179-186.
13. Davis, R.L.; Koup, J.R.; Williams-Warren, J.; Weber, A.; Heggen, L.; Stempel, D.; Smith, A.L. Pharmacokinetics of ciprofloxacin in cystic fibrosis. Antimicrob. Agents. Chemother., 1987, 31(3), 915-919.
14. Drusano, G.L.; Standiford, H.C.; Plaisance, K.; Forrest, A.; Leslie, J.; Caldwell, J.; Absolute oral bioavailability of ciprofloxacin. Antimicrob. Agents. Chemother., 1986, 30(3), 444-446.
15. Hoffler, D.; Dalhoff, A.; Gau, W.; Beermann, D.; Michl, A. Doseand sex-independent disposition of ciprofloxacin. Eur. J. Clin. Microbiol., 1984, 3(4), 363-366.
16. Dudley, M.N.; Ericson, J.; Zinner, S.H. Effect of dose on serum pharmacokinetics of intravenous ciprofloxacin with identification and characterization of extravascular compartments using noncompartmental and compartmental pharmacokinetic models. Antimicrob. Agents. Chemother., 1987, 31(11), 1782-1786.
17. Wise, R.; Donovan, I.A. Tissue penetration and metabolism of ciprofloxacin. Am. J. Med., 1987, 82(4A), 103-107.
18. Tietz, N.W. A model for a comprehensive measurement system in clinical chemistry. Clin. Chem., 1979, 25, 833-839.
19. Tanveer, A. W.; Nasr, Y. K.; Ibrahim, D.; Muzaffar, I.; Ahmed, H. B. Highly sensitive and simple validated ultra-performance liquid chromatography/tandem mass spectrometry method for the determination of cinacalcet in human plasma. Curr. Pharm. Anal., 2014, 10, 51-57.
20. Belal, F.; Al-Majed, A.A.; Al-Obaid, A.M. Methods of analysis of 4-quinolone antibacterials. Talanta, 1999, 50(4), 765-786.
21. Carlucci, G. Analysis of fluoroquinolones in biological fluids by high-performance liquid chromatography. J. Chromatogr. A., 1998, 812(1-2), 343-367.
22. Vybiralova, Z.; Nobilis, M.; Zoulova, J.; Kvetina, J.; Petr, P. Highperformance liquid chromatographic determination of ciprofloxacin in plasma samples. J. Pharm. Biomed. Anal., 2005, 37(5), 851-858.
23. Johnston, L.; Mackay, L.; Croft, M. Determination of quinolones and fluoroquinolones in fish tissue and seafood by highperformance liquid chromatography with electrospray ionisation tandem mass spectrometric detection. J. Chromatogr. A., 2002, 982(1), 97-109.
24. Muchohi, S.N.; Thuo, N.; Karisa, J.; Muturi, A.; Kokwaro, G.O.; Maitland, K. Determination of ciprofloxacin in human plasma using high-performance liquid chromatography coupled with fluorescence detection: application to a population pharmacokinetics study in children with severe malnutrition. J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci., 2011, 879(2), 146-152.
25. Hernandez-Arteseros, J.A.; Compano, R.; Prat, M.D. Determination of ciprofloxacin and enrofloxacin in edible animal tissues by terbium-sensitized luminescence. Analyst, 1998, 123(12), 2729-2732.
26. Hernandez-Arteseros, J.A.; Barbosa, J.; Compano, R.; Prat, M.D. Analysis of quinolone residues in edible animal products. J. Chromatogr. A., 2002, 945(1-2), 1-24.
27. Ueno, R.; Savgrungruang, K.; Miyakawa, M. A simplified method for the determination of several fish drugs in edible fish and shrimp by high-performance liquid chromatography. Food. Res. Int., 1999, 32(9), 629-633.
28. Mehta, A.C.; Hart-Davies, S.; Kay, E.A. High-performance liquid chromatographic determination of ciprofloxacin in plasma. J. Clin. Pharm. Ther., 1992, 17(2), 117-120.
29. Posyniak, A.; Zmudzki, J.; Semeniuk, S. Effects of the matrix and sample preparation on the determination of fluoroquinolone residues in animal tissues. J. Chromatogr. A., 2001, 914(1-2), 89-94.
30. Zotou, A.; Miltiadou, N. Sensitive LC determination of ciprofloxacin in pharmaceutical preparations and biological fluids with fluorescence detection. J. Pharm. Biomed. Anal., 2002, 28(3-4), 559-568.
31. Manceau, J.; Gicquel, M.; Laurentie, M.; Sanders, P. Simultaneous determination of enrofloxacin and ciprofloxacin in animal biological fluids by high-performance liquid chromatography. Application in pharmacokinetic studies in pig and rabbit. J. Chromatogr. B. Biomed. Sci. Appl., 1999, 726(1-2), 175-184.
32. Tyczkowska, K.L.; Voyksner, R.D.; Anderson, K.L.; Papich, M.G. Simultaneous determination of enrofloxacin and its primary metabolite ciprofloxacin in bovine milk and plasma by ion-pairing liquid chromatography. J. Chromatogr. B. Biomed. Appl., 1994, 658(2), 341-348.
33. Hubicka, U.; Zmudzki, P.; Zuromska-Witek, B.; Zajdel, P.; Pawłowski, M.; Krzek, J. Separation and characterization of ciprofloxacin, difloxacin, lomefloxacin, norfloxacin, and ofloxacin oxidation products under potassium permanganate treatment in acidic medium by UPLC-MS/MS. Talanta, 2013, 109, 91-100.
34. Danyi, S.; Widart, J.; Douny, C.; Dang, P.K.; Baiwir, D.; Wang, N.; Tu, H.T.; Tung, V.T.; Phuong, N.T.; Kestemont, P.; Scippo, M.L. Determination and kinetics of enrofloxacin and ciprofloxacin in Tra catfish (Pangasianodon hypophthalmus) and giant freshwaterprawn (Macrobrachium rosenbergii) using a liquid chromatography/ mass spectrometry method. J. Vet. Pharmacol. Ther., 2011, 34(2), 142-152.
35. Tang, H.P.; Ho, C.; Lai, S.S. High-throughput screening for multiclass veterinary drug residues in animal muscle using liquid chromatography/ tandem mass spectrometry with on-line solid-phase extraction. Rapid. Commun. Mass. Spectrom., 2006, 20, 2565-2572.
36. Guidance for industry: Bioanalytical Method Validation. U.S. Department of Health and Human Services. Food and Drug Administration. Rockville. MD, 2001.
37. Liu, J.P.; Chow, S.C. Design and analysis of bioavailability and bioequivalence studies. Third Edition ed.; Chapman and Hall/CRC, 2008.
38. Goodyear, M.D.; Krleza-Jeric, K.; Lemmens, T. The Declaration of Helsink. BMJ, 2007, 335(7621), 624-625.
39. Farrier, D.S. PK Solutions 2.0: Pharmacokinetics Data Analysis User Guide. Summit Research Services USA, 2005.
40. Zhai, S.; Korrapati, M.R.; Wei, X.; Muppalla, S.; Vestal, R.E. Simultaneous determination of theophylline, enoxacin and ciprofloxacin in human plasma and saliva by high-performance liquid chromatography. J. Chromatogr. B. Biomed. Appl., 1995, 669(2), 372-376.
41. CHMP. Guideline on validation of bioanalytical methods. (CHMP), C. f. m. p. f. h. u., Ed. (EMEA) European Medicines Agency: London, 2009.